Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Burosumab in adults with XLH
NCT02526160Phase 3Completed
- Sponsor
- Kyowa Kirin
- Start
- Oct 2015
- Primary completion
- Dec 2016
- Modality
- Monoclonal Antibodies
- Countries
- 7
01
Overview
A Phase 3 trial of burosumab in X-linked hypophosphatemia (XLH), sponsored by Kyowa Kirin. Started Oct 2015; status: completed.
02
Drugs
burosumab
03
Conditions
X-linked hypophosphatemia (XLH)
Beyond the preview
Go deeper on NCT02526160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02526160.